Loading...

ApoC-III: a potent modulator of hypertriglyceridemia and cardiovascular disease

PURPOSE OF REVIEW: To summarize the recent epidemiological, basic science, and pharmaceutical research linking apoC-III with the development and treatment of cardiovascular disease. RECENT FINDINGS: ApoC-III is an important emerging target linking hypertriglyceridemia with cardiovascular disease (CV...

Full description

Saved in:
Bibliographic Details
Published in:Curr Opin Endocrinol Diabetes Obes
Main Author: Kohan, Alison B.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524519/
https://ncbi.nlm.nih.gov/pubmed/25692924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000136
Tags: Add Tag
No Tags, Be the first to tag this record!